866-997-4948(US-Canada Toll Free)

Lab21 Limited - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Dec 2012

Category :

Surgical Equipment

No. of Pages : 26 Pages


Lab21 Limited (Lab21) is a personalized healthcare company. The company offers diagnostic products and services and supports medical diagnostics, blood bank screening and drug discovery. Lab21serves pharmaceutical and diagnostic firms and international healthcare providers. Lab21\'s diagnostic product division manufactures immuno-diagnostic kits and reagents which is focused on infectious diseases for the blood banking and clinical markets. Its clinical services operations provides high technology molecular assays and companion diagnostics. Lab21 has office in South Carolina, the US and Cambridge, the UK with a GMP manufacturing facility in Cambridge and other manufacturing sites in Camberley, Bridport and Newmarket. The company is headquartered in Cambridge, the UK.

The company plans to develop fully automated polymerase chain reaction based assays on the BD MAX platform as recently it entered into a collaboration with Becton, Dickinson and Company.

This report is a source for data, analysis and actionable intelligence on the Lab21 Limited portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 3
Key Facts 4
Lab21 Limited - Major Products and Services 5
Lab21 Limited Pipeline Products by Equipment Type 6
Lab21 Limited Pipeline Products by Development Stage 8
Lab21 Limited Pipeline Products by Therapy Area 10
Lab21 Limited Pipeline Products by Milestone Summary 12
Companion Diagnostic Test - Infectious Disease 14
Companion Diagnostic Test - Infectious Disease Product Status 14
Companion Diagnostic Test - Infectious Disease Product Description 14
MycAssay Aspergillus Test 15
MycAssay Aspergillus Test Product Status 15
MycAssay Aspergillus Test Product Description 15
MycAssay Aspergillus Test Product Milestone 15
MycAssay Pneumocystis Test 17
MycAssay Pneumocystis Test Product Status 17
MycAssay Pneumocystis Test Product Description 17
MycAssay Pneumocystis Test Product Milestone 17
Onconostica 19
Onconostica Product Status 19
Onconostica Product Description 19
Lab21 Limited - Key Competitors 20
Lab21 Limited - Key Employees 21
Lab21 Limited - Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Lab21 Limited, Recent Developments 23
Jun 26, 2012: Lab21 partners pharmaceutical Company To Develop New Companion Diagnostic Assay 23
May 15, 2012: Lab21 Secures European And US Patents For HCV Drug Resistance Genotyping 23
May 11, 2012: Lab21 Unveils New Molecular Analysis Services At Greenville Site 24
Mar 06, 2012: Lab21 And ITOR Launch Clinical Genomics Center In US 24
Feb 20, 2012: Lab21 Appoints Fraser Logue As Director Of Quality, Regulatory Affairs And Operations Excellence 24
Feb 16, 2012: Lab21 Launches New Lung Cancer Companion Diagnostic Service 25

Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Table


Lab21 Limited, Key Facts 1
Lab21 Limited Key Pipeline Products by Equipment Type 1
Lab21 Limited Key Pipeline Products by Therapy Area 1
Lab21 Limited Key Pipeline Products by Development Stage 1
Lab21 Limited, Key Facts 4
Lab21 Limited, Major Products and Services 5
Lab21 Limited Number of Pipeline Products by Equipment Type 6
Lab21 Limited Pipeline Products by Equipment Type 7
Lab21 Limited Number of Pipeline Products by Development Stage 8
Lab21 Limited Pipeline Products by Development Stage 9
Lab21 Limited Number of Pipeline Products by Therapy Area 10
Lab21 Limited Pipeline Products by Therapy Area 11
Lab21 Limited Number of Pipeline Products By Milestone Summary 12
Lab21 Limited Pipeline Products by Milestone Summary 13
Companion Diagnostic Test - Infectious Disease - Product Status 14
Companion Diagnostic Test - Infectious Disease - Product Description 14
MycAssay Aspergillus Test - Product Status 15
MycAssay Aspergillus Test - Product Description 15
MycAssay Aspergillus Test - Product Milestone 15
MycAssay Pneumocystis Test - Product Status 17
MycAssay Pneumocystis Test - Product Description 17
MycAssay Pneumocystis Test - Product Milestone 17
Onconostica - Product Status 19
Onconostica - Product Description 19
Lab21 Limited, Key Employees 21
Lab21 Limited, Subsidiaries 22

List of Chart


Lab21 Limited Key Pipeline Products by Equipment Type 1
Lab21 Limited Pipeline Products by Equipment Type 6
Lab21 Limited Pipeline Products by Development Stage 8
Lab21 Limited Pipeline Products by Therapy Area 10
Lab21 Limited Pipeline Products by Milestone Summary 12

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *